Skip to main content

Use of Iron Therapy for Pediatric Patients

CBE ID
1433
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

Percentage of all pediatric (less than 18 years old) in-center hemodialysis, home hemodialysis, and peritoneal dialysis patients with hemoglobin less than 11.0 g/dL and in whom serum ferritin concentration was less than 100 ng/ml and TSAT less than 20% who received IV iron or were prescribed oral iron within the following three months.

        • 1.14 Numerator

          Number of patients in the denominator who received IV iron or were prescribed oral iron within three months following the first occurrence of serum ferritin <100 ng/mL and transferrin saturation (TSAT) <20% during the study period.

        • 1.15 Denominator

          All pediatric (less than 18 years old) in-center hemodialysis, home hemodialysis, and peritoneal dialysis patients with hemoglobin less than 11 g/dL and in whom serum ferritin was less than 100 ng/mL and TSATless than 20% during the three month study period.

        • Exclusions

          None.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed National Voluntary Consensus Standards for End Stage Renal Disease
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          Centers for Medicare & Medicaid Services
          Steward Organization POC Email